The effect of montmorillonite in graphene oxide/chitosan nanocomposite on controlled release of gemcitabine

[1] Yang Y(2009)Preparation and properties of a novel drug delivery system with both magnetic and bimolecular targeting J Mater Sci Mater Med 20 301-307

[2] Jiang J(2019)Cyclodextrin-based delivery systems for cancer treatment Mater Sci Eng C 96 872-886

[3] Du B(2016)Polymer assembly: promising carriers as co-delivery systems for cancer therapy Prog Polym Sci 58 1-26

[4] Gan ZF(1995)Fludarabine-and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event Can Chemother Pharmacol 36 181-188

[5] Qian M(2016)Loading of gemcitabine on chitosan magnetic nanoparticles increases the anti-cancer efficacy of the drug Eur J Pharmacol 5 121-128

[6] Zhang P(2019)Potential of Chitosan and its derivatives for controlled drug release applications—a review J Drug Deliv Sci Technol 49 642-659

[7] Zhang D(2011)Carbon materials for drug delivery and cancer therapy Mater Today 14 316-323

[8] Lv P(2018)Montmorillonite as imaging and drug delivery agent for cancer therapy Appl Clay Sci 162 469-477

[9] Zhou C(2016)Novel carboxymethyl chitosan-graphene oxide hybrid particles for drug delivery J Mater Sci Mater Med 27 169-820

[10] Zhao Y(2016)Lactobionic acid and carboxymethyl chitosan functionalized graphene oxide nanocomposites as targeted anticancer drug delivery systems Carbohydr Polym 151 812-151

[1] Yang Y(2009)Preparation and properties of a novel drug delivery system with both magnetic and bimolecular targeting J Mater Sci Mater Med 20 301-307

[2] Jiang J(2019)Cyclodextrin-based delivery systems for cancer treatment Mater Sci Eng C 96 872-886

[3] Du B(2016)Polymer assembly: promising carriers as co-delivery systems for cancer therapy Prog Polym Sci 58 1-26

[4] Gan ZF(1995)Fludarabine-and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event Can Chemother Pharmacol 36 181-188

[5] Qian M(2016)Loading of gemcitabine on chitosan magnetic nanoparticles increases the anti-cancer efficacy of the drug Eur J Pharmacol 5 121-128

[6] Zhang P(2019)Potential of Chitosan and its derivatives for controlled drug release applications—a review J Drug Deliv Sci Technol 49 642-659

[7] Zhang D(2011)Carbon materials for drug delivery and cancer therapy Mater Today 14 316-323

[8] Lv P(2018)Montmorillonite as imaging and drug delivery agent for cancer therapy Appl Clay Sci 162 469-477

[9] Zhou C(2016)Novel carboxymethyl chitosan-graphene oxide hybrid particles for drug delivery J Mater Sci Mater Med 27 169-820

[10] Zhao Y(2016)Lactobionic acid and carboxymethyl chitosan functionalized graphene oxide nanocomposites as targeted anticancer drug delivery systems Carbohydr Polym 151 812-151